SynAct Pharma Alternatives & Competitors
12 companies similar to SynAct Pharma — Resolving Inflammation Through Melanocortin Biology
Companies similar to SynAct Pharma
Cyxone
Life-changing treatments for disorders of the immune system
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
LIPUM AB
We have developed a biological drug SOL-116 for treatment of chronic inflammatory diseases
Palatin Technologies
We discover and develop novel therapeutics for patients living with inflammatory and autoi...
Rival Readout
Competing with SynAct Pharma? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Omeros Corporation
Let science lead the way
Creative BioTherapeutics LLC
An emerging biotech discovering & developing novel therapies for cancer and viruses where...
Bioniz, LLC
Pioneering the future of autoimmune and cancer treatment with innovative small peptides an...
Quince Therapeutics
Dedicated to unlocking the power of a patient’s own biology for the treatment of rare dise...
Atom Therapeutics
Atom Therapeutics Co., Ltd
ConoGenetix biosciences
Pioneering peptide therapeutics to combat autoimmune diseases.
ImmunOs Therapeutics AG
Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific r...
About SynAct Pharma
SynAct Pharma is a biotech company based in Sweden, founded in 2012, with a focus on resolving inflammation through melanocortin biology. Their lead asset, AP1189, is currently in phase 2 development for the treatment of rheumatoid arthritis. The drug is an immunomodulatory small molecule delivered as a once-daily tabl...
Biotech, Drug Development, Immunomodulatory, Rheumatoid Arthritis Treatment, Inflammation Resolution, Melanocortin Biology, Small Molecule Therapeutics, COVID-19 Treatment, Respiratory Insufficiency, Autoimmune Diseases, Clinical Trials, Pharmaceutical Partnerships, Preclinical Studies, Joint Disorders, Commercial Agreements
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around SynAct Pharma: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at SynAct Pharma on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.